ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 112 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $139,171 | -5.8% | 20,317 | +42.6% | 0.00% | 0.0% |
| Q2 2023 | $147,700 | +87.1% | 14,243 | +45.9% | 0.00% | – |
| Q1 2023 | $78,950 | -48.6% | 9,759 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $153,704 | +30.3% | 9,759 | +30.1% | 0.00% | 0.0% |
| Q3 2022 | $118,000 | +12.4% | 7,501 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $105,000 | -18.6% | 7,501 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $129,000 | +18.3% | 7,501 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $109,000 | +87.9% | 7,501 | +133.6% | 0.00% | – |
| Q3 2021 | $58,000 | +427.3% | 3,211 | +76.6% | 0.00% | – |
| Q1 2019 | $11,000 | -15.4% | 1,818 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | -50.0% | 1,818 | 0.0% | 0.00% | – |
| Q3 2018 | $26,000 | -27.8% | 1,818 | 0.0% | 0.00% | – |
| Q2 2018 | $36,000 | +12.5% | 1,818 | 0.0% | 0.00% | – |
| Q1 2018 | $32,000 | -28.9% | 1,818 | 0.0% | 0.00% | – |
| Q4 2017 | $45,000 | +32.4% | 1,818 | +39.7% | 0.00% | – |
| Q3 2017 | $34,000 | -2.9% | 1,301 | 0.0% | 0.00% | – |
| Q2 2017 | $35,000 | -75.5% | 1,301 | -72.9% | 0.00% | -100.0% |
| Q1 2017 | $143,000 | +308.6% | 4,801 | +269.0% | 0.00% | – |
| Q4 2016 | $35,000 | – | 1,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |